周林副教授、魏少华教授课题组在JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY发表研究论文

时间:2021-04-06 10:48:29学院:化学与材料科学学院学校:南京师范大学

A ROS responsive nanomedicine with enhanced photodynamic therapy via dual mechanisms: GSH depletion and biosynthesis inhibition
Hu, JH (Hu, Jinhui)[ 1 ] ; Wang, T (Wang, Ting)[ 1 ] ; Zhou, L (Zhou, Lin)[ 1 ]*(周林); Wei, SH (Wei, Shaohua)[ 1,2 ]*(魏少华)

[ 1 ] Nanjing Normal Univ, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Key Lab Appl Photochem, Coll Chem & Mat Sci,Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China
[ 2 ] Yancheng Inst Technol, Sch Chem & Chem Engn, Yancheng 224051, Jiangsu, Peoples R China

 

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY,202008,209,111955

 

Reduced glutathione (GSH, containing sulfydryl) inside cancer cells strongly consumes reactive oxygen species (ROS) in photodynamic therapy (PDT) process to reduce PDT effect. Thiol-ene click reaction is a classic method to couple sulfydryl and alkene groups. However, little effort was dedicated to developing medicines for GSH depletion based on this reaction. Our research indicated that GSH could effectively couple with docosahexaenoic acid (DHA, as alkene) in the presence of 2,2-dimethoxy-2-phenylacetophenone (DMPA, as photo-initiator) post 665 nm light irradiation through the thiol-ene click reaction. Based on this result, a ROS responsive nanocarrier (denoted as RSV) was used to load photosensitizer (zinc phthalocyanine, ZnPc), DHA and DMPA (denoted as DDRZ NP). Our research demonstrated that DDRZ NP could effectively accumulate at tumor tissue post tail vein injection. After irradiated by 665 nm light at tumor tissue, RSV was broken by ROS to release the encapsulated drugs. After that, the thiol-ene click reaction was initiated to couple GSH and DHA to deplete intracellular GSH. In addition, DDRZ NP destroyed GSH biosynthesis limiting enzyme, gamma-glutamylcysteine synthetase (gamma-GCS), to inhibit intracellular GSH biosynthesis. Above dual mechanisms, by GSH depletion and biosynthesis inhibition, could effectively guarantee intracellular GSH concentration decreasing to ensure satisfactory PDT cancer treatment outcome.

文章链接:
https://www.sciencedirect.com/science/article/pii/S101113442030405X?via%3Dihub



版权与免责声明:本网页的内容由收集互联网上公开发布的信息整理获得。目的在于传递信息及分享,并不意味着赞同其观点或证实其真实性,也不构成其他建议。仅提供交流平台,不为其版权负责。如涉及侵权,请联系我们及时修改或删除。邮箱:sales@allpeptide.com

返回首页 浙公网安备 33010602009704号;浙ICP备18001318号